About Pharmaceutical Manufacturing License in India
A pharmaceutical manufacturing licence in India is a statutory approval under the Drugs and Cosmetics Act, 1940 and Rules, 1945, issued by the competent authority for lawful drug manufacturing activities.
Why It Matters
Pharmaceutical manufacturing operates under stringent regulatory requirements. Licence holders must maintain applicable GMP standards, while drug authorities conduct inspections and verify ongoing compliance with prescribed manufacturing and quality requirements continuously.
Who Needs It
Companies manufacturing pharmaceutical formulations, APIs, veterinary medicines, or specified traditional medicines may require licences from the competent regulatory authority, depending on product category and applicable legislation.
Types of Pharmaceutical Manufacturing Licensing Services Covered
IMARC Engineering supports pharmaceutical manufacturers in identifying the correct pharmaceutical manufacturing license in India type and regulatory authority based on drug category, dosage form, manufacturing scale, and whether the application falls under state or central jurisdiction.
Allopathic Manufacturing Licence
Support for manufacturers of oral solid dosage forms, injectables, topicals, liquids, and other allopathic formulations seeking pharmaceutical manufacturing licences under regulatory requirements and State Drug Control Authority approvals and documentation.
Bulk Drug (API) Manufacturing Licence
Guidance for active pharmaceutical ingredient (API) manufacturers seeking drug manufacturing licences, covering applicable regulatory documentation, technical requirements, facility compliance, and application support for obtaining manufacturing approval from competent regulatory authorities.
Loan Licence for Pharmaceutical Manufacturing
Support for businesses seeking loan licences to manufacture pharmaceutical products at another licensed manufacturer's facility, covering documentation, regulatory requirements, manufacturing arrangements, and application support for obtaining approvals through regulatory authorities.
Repacking and Relabelling Licence
Assistance for businesses engaged in pharmaceutical repacking or relabelling, covering applicable licensing requirements, documentation, facility compliance, regulatory applications, and coordination with the State Drug Control Authority for approval and submissions.
Ayurvedic, Unani, and Homeopathic Licence
Support for manufacturers of Ayurvedic, Siddha, Unani, and Homeopathic medicines seeking applicable manufacturing licences, covering documentation, facility requirements, regulatory compliance, and application support under relevant state rules and procedures accordingly.
Regulatory Requirements of License
Guidance for existing pharmaceutical manufacturing license in India holders seeking to add new drug products or dosage forms, expand manufacturing capacity, change premises, or renew their pharma regulatory approval before expiry.
Pharmaceutical Manufacturing License Registration Process in India
A structured approach to pharmaceutical manufacturing license in India applications prevents facility redesign, documentation rejections, and inspection failures that delay manufacturing commencement and pharma regulatory approval.
Step 1
Drug Category, Dosage Form, and Authority Identification
Confirm the drug category, dosage forms, and manufacturing activities involved to identify the correct pharmaceutical manufacturing license in India type and determine whether the application is filed with the State Drug Control Authority or CDSCO.
Step 2
GMP and Facility Compliance Gap Assessment
Review the manufacturing facility, whether under construction, newly commissioned, or existing, against Schedule M GMP requirements under the Drugs and Cosmetics Rules. Identify gaps which directly determine inspection outcomes for the drug manufacturing license application.
Step 3
Technical Documentation Preparation
Prepare the full documentation package required under Schedule M for the pharmaceutical manufacturing licence application.
Step 4
Application Filing with State Drug Controller or CDSCO
File the pharmaceutical manufacturing license in India application in the prescribed form with the State Drug Control Authority for formulation and ASU&H licences, or with CDSCO for bulk drug and products requiring CDSCO pharmaceutical approval.
Step 5
GMP Inspection Readiness and Coordination
Support readiness for the facility inspection conducted by Drug Inspectors from the State Drug Control Authority or CDSCO.
Step 6
Licence Issuance and Post-Approval Compliance
Follow through until the pharmaceutical manufacturing license in India is issued. Support post-approval compliance including periodic GMP inspection preparation, product addition filings, schedule drug record maintenance, licence renewal, change in premises applications, and ongoing obligations.
Documents Required for Pharmaceutical Manufacturing License in India
Document requirements for pharmaceutical manufacturing license in India vary by drug category, dosage form, licence type, and whether the application is filed with the State Drug Control Authority or CDSCO for CDSCO pharmaceutical approval.
- Company registration and constitution documents
- Site master file and facility layout plan
- Qualified person certificates (pharmacist/technical director)
- Equipment list and qualification status records
- GMP compliance declaration and Schedule M alignment report
- Standard operating procedures (SOPs) index
- Water system validation and environmental monitoring data
- Product master formula and manufacturing batch records
Industries We Support
Pharmaceutical manufacturing license in India consultancy support is applicable across all pharmaceuticals, biopharmaceutical, and healthcare manufacturing segments requiring a valid pharma manufacturing license or medicine manufacturing license under the Drugs and Cosmetics Act.
- Oral solid dosage form manufacturers (tablets, capsules)
- Injectable and sterile product manufacturers
- Active pharmaceutical ingredient (API) producers
- Biopharmaceutical and biosimilar manufacturers
- Ayurvedic, Unani, and Homeopathic medicine manufacturers
- Veterinary drug and nutraceutical manufacturers
- Contract manufacturing organisations (CMOs)
- Ophthalmic, topical, and liquid formulation producers
How IMARC Engineering Supports Pharmaceutical Manufacturing License in India
Our approach combines pharmaceutical regulatory expertise with engineering and facility knowledge, enabling manufacturers to pursue a pharmaceutical manufacturing license in India with well-prepared documentation, GMP-aligned facilities, and a clear compliance pathway from application to post-approval.
Regulatory Assessment and Licence Planning
We help pharmaceutical manufacturers determine the correct pharmaceutical manufacturing license in India category, applicable authority, dosage form scope, and qualified person requirements at the outset. Early regulatory planning ensures that pharma regulatory approval timelines are integrated into the facility commissioning and product launch schedule.
GMP Facility Alignment and Documentation
We support pharmaceutical manufacturers in aligning their facility design, cleanroom and HVAC systems, water systems, equipment qualification, and quality management documentation with Schedule M GMP requirements, and assist in preparing the full documentation package required for the drug manufacturing license or pharma manufacturing license application.
Inspection Readiness and Post-Licence Compliance
We assist manufacturers in preparing for Drug Inspector visits and GMP audits, conducting pre-inspection reviews, identifying corrective actions, and supporting documentation readiness for the CDSCO pharmaceutical approval or State Drug Controller inspection.
Need Pharmaceutical Manufacturing License Support in India?
FAQs
Answers to key questions from pharmaceutical manufacturers, investors, CMOs, and new entrants about pharmaceutical manufacturing license, GMP requirements, and the regulatory approval process.
A pharmaceutical manufacturing license in India is a statutory approval under the Drugs and Cosmetics Act, 1940, that authorises a manufacturer to produce drugs for sale, distribution, or export. The applicable manufacturing licence form depends on the drug category, applicable Schedule and manufacturing activity. For example, Form 25 and Form 28 apply to different categories of drugs under the Drugs Rules, while separate forms apply to loan licences and other specialised manufacturing activities.
The pharmaceutical manufacturing license in India is generally issued by the State Drug Control Authority or Licensing Authority of the respective state under the Drugs and Cosmetics Act, 1940. Depending on the product category, certain approvals, permissions, or regulatory oversight may also involve CDSCO. The applicable authority and approval pathway depend on the type of product and manufacturing activity.
GMP compliance in India for pharmaceutical manufacturers is governed by Schedule M of the Drugs and Cosmetics Rules, 1945, which was significantly revised in 2023 to align with WHO GMP guidelines. Schedule M prescribes requirements for premises design and layout, HVAC and cleanroom classification, water system quality, equipment qualification and calibration, personnel hygiene and qualification, documentation systems, change control, and product quality review.
The terms drug manufacturing license and pharma manufacturing license refer to the same statutory approval under the Drugs and Cosmetics Act. The former is the technical regulatory term used in the Act and Rules, while the latter is the commonly used industry term. Both refer to the pharmaceutical manufacturing license in India issued under Form 25 or Form 28, authorising the manufacture of pharmaceutical products.
Yes. A loan licence for pharmaceutical manufacturing allows a business to manufacture drugs at the GMP-approved facility of another licenced manufacturer, without owning a manufacturing plant. The loan licensee is responsible for product quality, labelling, and regulatory compliance, while actual manufacturing is carried out at the lending manufacturer's facility under a formal agreement.
Timelines for a pharmaceutical manufacturing license in India vary by state, drug category, and facility readiness. For formulation manufacturers, the State Drug Controller typically processes applications within 3 to 6 months, subject to document completeness and inspection scheduling. CDSCO pharmaceutical approval for bulk drug manufacturers may take 6 to 12 months.
Yes. A pharmaceutical manufacturing license in India is issued for a specified validity period, typically five years in most states, and must be renewed before expiry. Renewal requires continued GMP compliance in India, updated technical documentation, and confirmation that the facility, qualified personnel, and quality systems remain compliant with Schedule M requirements.
Yes. An existing pharmaceutical license in India holder can apply for addition of new drug products or dosage forms through an amendment or endorsement filing with the relevant licensing authority. The addition of a new dosage form, such as injectables to an existing oral solid dosage form licence, may require separate facility inspection and GMP compliance in India verification for the new manufacturing area.
The Drugs and Cosmetics Rules prescribe minimum qualifications for the technical person responsible for manufacturing operations, referred to as the Competent Technical Staff (CTS) or Technical Director, as a condition of the pharmaceutical manufacturing license in India.
IMARC Engineering provides end-to-end consultancy for pharmaceutical manufacturing license in India, from drug category assessment and authority identification to GMP compliance in India gap assessment, facility alignment, documentation preparation, drug manufacturing license and pharma manufacturing license application filing, inspection readiness, and post-approval compliance advisory. Our team supports formulation manufacturers, API producers, CMOs, and ASU&H manufacturers in obtaining CDSCO pharmaceutical approval or State Drug Controller licences, with a structured approach that reduces application deficiencies, inspection failures, and delays in pharma regulatory approval.
Trusted by Industry Leaders
We partner with global enterprises and ambitious businesses across sectors to deliver operational excellence, strategic insights, and sustainable growth through integrated solutions.
Success in Their Words
Real feedback from clients across industries. Discover how our solutions delivered measurable impact and operational excellence.
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have been truly commendable, and it is evident that you have put in tremendous hard work and expertise into resolving the issues at hand. We are greatly interested in continuing our collaboration with you in the future, as your professionalism and reliability have made you a trusted partner. Thank you once again for your invaluable contribution. We look forward to strengthening our partnership ahead.
It has been a pleasure working with the IMARC team. The insights provided were structured, clear, and highly valuable, helping us strengthen both our technical and financial planning with confidence. We deeply appreciate the team’s professionalism, responsiveness, and attention to detail throughout the engagement. Every requirement was well understood and effectively incorporated, resulting in a comprehensive and actionable output. Overall, our experience has been excellent, and I would gladly recommend IMARC to organizations seeking a reliable research partner.
Your service is truly exceptional. Working with the IMARC team has been a seamless and professional experience. The clarity of communication, responsiveness to queries, and consistent support at every stage made the entire engagement highly efficient. The insights shared were well-structured, practical, and perfectly aligned with our requirements, helping us make informed decisions with confidence. Overall, the dedication and professionalism demonstrated by your team stand out, and I would be glad to recommend IMARC as a reliable and trustworthy research partner.
IMARC did an outstanding job in preparing our study. They were punctual, precise, and consistently responsive throughout the entire process. The team delivered all the data we required in a clear, well-organized, and highly professional format. Their strong attention to detail, combined with their ability to meet every deadline without compromising quality, truly set them apart. Overall, their reliability and commitment made them an exceptional partner for our project, and we would gladly work with them again in the future.
IMARC made the whole process incredibly easy from start to finish. Everyone I interacted with via email was polite, professional, and straightforward to deal with, always keeping their promises regarding delivery timelines and remaining consistently solutions-focused. From my very first contact, I appreciated the professionalism and support shown by the entire IMARC team. I highly recommend IMARC to anyone seeking timely, affordable, and reliable information or advice. My experience with IMARC was excellent, and I truly cannot fault any aspect of it.
I’d like to express my sincere gratitude for the excellent work you accomplished with the study. Your ability to quickly understand our requirements and deliver high-quality results under tight timelines truly reflects your expertise, exceptional work ethic, and unwavering commitment to your customer’s success. The professionalism and responsiveness you demonstrated throughout the process made a significant difference. Our entire team and company are incredibly thankful for your dedication, reliability, and support. Once again, thank you for your outstanding contribution.